Single immunization with an influenza hemagglutinin nanoparticle‐based vaccine elicits durable protective immunity
Abstract Vaccination is the most effective strategy to combat influenza. Ideally, potent and persistent vaccine effects would be induced with a single vaccine dose. Here, we designed a virus‐like particle (VLP)‐based vaccine presenting multiple copies of the influenza hemagglutinin (HA) from A/Puert...
Saved in:
Main Authors: | Shiho Chiba (Author), Tadashi Maemura (Author), Kathryn Loeffler (Author), Steven J. Frey (Author), Chunyang Gu (Author), Asim Biswas (Author), Masato Hatta (Author), Yoshihiro Kawaoka (Author), Ravi S. Kane (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potent neutralization of SARS‐CoV‐2 including variants of concern by vaccines presenting the receptor‐binding domain multivalently from nanoscaffolds
by: Peter J. Halfmann, et al.
Published: (2021) -
Effect of [6]-gingerol on viral neuraminidase and hemagglutinin-specific T cell immunity in severe influenza
by: Avijit Dutta, et al.
Published: (2023) -
Inactivated influenza virus vaccines expressing COBRA hemagglutinin elicited broadly reactive, long-lived protective antibodies
by: Hua Shi, et al.
Published: (2024) -
Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge
by: Hyesun Jang, et al.
Published: (2020) -
DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs
by: Kathleen A. Cashman, et al.
Published: (2017)